Molecular mechanisms of alcohol-induced liver injury: An update

Minerva Gastroenterologica e Dietologica

Volumn 49, Issue 2, 2003, Pages 95-105

  Surrenti, C ^a   Galli, A ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Ethanol; Liver; Liver diseases, alcoholic, diagnosis; Liver diseases, alcoholic, genetics; Liver diseases, alcoholic, physiopathology

Indexed keywords

ALDEHYDE; CELL NUCLEUS RECEPTOR; ENDOTOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; CYTOKINE RELEASE; ENDOTHELIUM CELL; FATTY LIVER; GENETIC PREDISPOSITION; GENETICS; HUMAN; KUPFFER CELL; LIPID METABOLISM; LIVER DISEASE; LIVER INJURY; MOLECULAR MECHANICS; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; REVIEW; STELLATE CELL;

EID: 0346967307     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Grunnet N, Kondrup J. The effect of ethanol on the beta oxidation of fatty acids. Alcohol Clin Exp Res 1986; 10:64S-68S.
2. Lieber CS, Lefevre A, Spritz N, Freinman L, DeCarli LM. Difference in hepatic metabolism of long- and medium-fatty acids chain length in the production of the alcoholic fatty liver. J Clin Invest 1967;46:1451-60.
3. Lieber CS. Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol Clin Exp Res 1991;15:573-92.
4. Kurose I, Higuchi H, Kato S, Miura S, Waranabe N, Kamegaya Y et al. Oxidative stress on mitochondria and cell membrane of cultured hepatocytes and perfused liver exposed to ethanol. Gastroenterology 1997;112:1331-43.
5. Bailey SM, Cunningham CC. Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. Hepatology 1998;28:1318-26.
6. Clemens DL, Halgard CM, Rodney RR, Sorrell MF, Tuma DJ. Establishment of a recombinant cell line stably expressing alcohol dehydrogenase. Arch Biochem Biophis 1995;321:311-8.
7. Galli A, Price D, Crabb DW. High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced HeLa cells. Hepatology 1999;29:1164-70.
8. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS et al. Fatty acids and ecosanoids regulate gene expression through direct interaction with peroxisome proliferator-activated receptor α and γ. Proc Natl Acad Sci USA 1997;94:4318-23.
9. Bocos C, Gottlicher M, Gearing K, Banner C, Enmark E, Teboul M et al. Fatty acids activation of peroxisome proliferator-activated receptor (PPAR). J Steroid Biochem Mol Biol 1995;53:467-73.
10. Everett L, Galli A, Crabb D. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver 2000;20:191-9.
11. Lee SS, Pineau T, Drago J, Lee JJ, Owens JW, Kroetz DL et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995;15:3012-22.
12. Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW. Espression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 1995;56:307-17.
13. Galli A, Pinaire J, Fisher M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor α is inhibited by ethanol metabolism. J Biol Chem 2001;276:68-75.
14. Salaspuro MP, Shaw S, Jayatilleke E, Ross WA, Lieber CS. Attenuation of the ethanol-induced hepatic redox change after chronic alcohol consumption in baboons: metabolic consequences in vivo et in vitro. Hepatology 1981;1:33-8.
15. You M, Fisher M, Deeg MA, Crabb DW. Ethanol induces fatty acids synthesis pathways by activation of sterol regulatory element binding protein (SREBP). J Biol Chem 2002 [in press].
16. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party. Hepatology 1998;27:1463-6.
17. Letteron P, Framenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996;24:200-8.
18. Geubre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulation in obesity-related murine fatty livers: potential mechanism for sensitization to the liver damage. Hepatology 2000;31:633-40.
19. Eriksson PCJ. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 2001; 25:15S-32S.
20. Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 2000; 32:113-28.
21. Willis MS, Klassen LW, Tuma DJ, Thiele GM. Different levels of protein adduction by alcohol metabolites induce antibody and T cell responses specific to the carrier protein in a dose dependent manner. Hepatology 1997;26:254A.
22. Lin RC, Lumemg L. Further studies on the 37 kD liver protein-acetaldehyde adduct that form in vivo during chronic alcohol ingestion. Hepatology 1989;10:807-14.
23. 4-3-ketosteroid-5β-reductase (the 37kd-liver protein) in the pathogenesis of alcoholic liver injury in the rat. Hepatology 1998;27: 100-7.
24. Tsukamoto H, Lu SC. Current concept in the pathogenesis of alcoholic liver injury. FASEB J 2001;15:1335-49.
25. Casini A, Cunningham M, Rojkind M, Lieber SC. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat storing cells through a protein synthesis-dependent mechanism. Hepatology 1991;13:758-65.
26. Casini A, Ceni E, Salzano R, Biondi P, Parola M, Galli A et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 1997;25:361-7.
27. Parola M, Pinzani M, Casini A, Leonarduzzi G, Marra F, Caligiuri A et al. Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is releted to their molecular structure. Biochem Biophys Res Com 1996;222:261-4.
28. Svegliati-Baroni G, Ridolfi F, Di Sario A, Saccomanno S, Bendia E, Benedetti A, et al. Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells. Hepatology 2001;33:1130-40.
29. Casini A, Galli G, Salzano R, Ceni E, Franceschelli F, Rotella CM et al. Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat storing cell cultures trough protein kinase C activation. Alcohol Alcoholism 1994;29:303-14.
30. Chung KY, Agarwal A, Uitto J, Muviel A. An AP-1 binding sequences is essential for regulation of the human 2α(1) collagen (COLIA2) promoter activity by transforming growth factor-β. J Biol Chem 1996;271:3272-8.
31. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Surrenti C et al. Peroxisome proliferator-activated receptor gamma transcriptional activity is inhibited by acetaldehyde in human hepatic stellate cells. J Hepatol 2001;34 (suppl 1):A376.
32. Galli A, Crabb DW, Price D, Ceni E, Salzano R, Surrenti C et al. Peroxisome proliferator activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation in human hepatic stellate cells. Hepatology 2000;31:101-8.
33. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cells activation in vivo and in vitro. Gastroenterology 2002;122:1924-40.
34. Anania FA, Womack L, Jiang M, Saxena KM. Aldeydes potentiate α2(I) collagen gene activity by JNK in hepatic stellate cells. Free Rad Biol Med 2001;30:846-57.
35. Chen A, Davis HD. The DNA binding protein BTEB mediates acetaldehyde-induced Jun N-terminal kinase-dependent αI(I) collagen gene expression in rat hepatic stellate cells. Mol Cel Biol 2000;20:2818-26.
36. Greenwel P, Domiguez-Rosales JA, Mavi G, Rivas-Estilla M, Rojkind M. Hydrogen peroxide: a link between acetaldehyde-elicited αI(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology 2000;31:109-16.
37. Roman J, Gimenez A, Lluis JM, Grasso M, Rubio M, Cabelleria J et al. Enhanced DNA binding and activation of transcription factors NF-kB and AP-1 by acetaldehyde in HEPG2 cells. J Biol Chem 2000;275:14684-90.
38. Thiele GM, Worral S, Tuma JD, Klassen LW, Wyatt TA, Nagata N. The chemistry and biological effects of malondialdehyde-acetaldehyde adducts. Alcohol Clin Exp Res 2001;25:218S-224S.
39. Tuma DJ, Thiele GM, Xu D, Classen LW, Sorrel MF. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long term ethanol administration. Hepatology 1996;23:872-80.
40. Thiele GM, Miller JA, Klassen LW, Tuma DJ. Long-term ethanol administration alters the degradation of acetaldehyde adducts by liver endothelia cells. Hepatology 1996;24:643-8.
41. Thiele GM, Miller JA, Klassen LW, Tuma DJ. Chronic ethanol consumption impairs receptor-mediated endocytosis of formaldehyde treated albumin by isolated rat liver endothelial cells. Hepatology 1999; 29:1511-7.
42. Thiele GM, Tuma DJ, Willis MS, Miller JA, Mc Donald TL, Sorrell MF et al. Soluble proteins modified with acetaldehyde and molondialdehyde are immunogenic in the absence of adjuvant. Alcohol Clin Exp Res 1998; 22:1731-9.
43. Miller JA, Klassen LW, Duryee MJ, Tuma DJ, Thiele GM. Increased adhesion molecule and TNF-alpha expression by liver endothelial cells after exposure to MAA-modified proteins. Hepatology 1997;26:330A.
44. Jarnagin WR, Rockey DC, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Biol Chem 1994; 127:2037-48.
45. Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P4502E1-dependent formation of hydroxyl free radical in the development of liver damage in rats ingtragastric fed with ethanol, Hepatology 1996;23:155-63.
46. Clot P, Albano E, Eliasson E, Tabone M, Arico S, Israel Y et al. Cy6tochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology 1996;111:206-16.
47. Clot P, Parola M, Bellomo G, Dianzani U, Carini, Tabone Metal. Plasma membrane hydroxyethil radical adducts cause antibody dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 1997;113: 265-76.
48. Casini A. Alcohol-induced fatty liver and inflammation: where do kupffer cells act? J Hepatol 2000;32:1026-30.
49. Stahnke LL, Hill BD, Allen JI. TNF-a and IL-6 in alcoholic liver disease. In: Wisse E, Knock DL, McCuskey RS, editors. Cells of hepatic sinusoid. Leiden: Kupffer cell Fundation 1991:472-5.
50. Enamoto M, Ikejama K, Bradford BU, Rivera CA, Kono H, Goto M et al. Role of kupffer cells and gut derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol 2000;15:D20-D25.
51. Shibayama Y, Nakata K, Asaka S. Endotoxin hepatotoxycity augmented by ethanol. Exp Mol Pathol 1991; 55:196-202.
52. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Inactivation of kupffer cells prevents early alcohol induced liver injury. Hepatology 1994;20:453-60.
53. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-3.
54. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76.
55. Bellezzo JM, Britton RS, Bacon BR, Fox ES. LPS-mediated NF-kB activation in rat kupffer cells can be induced independently of CD14. Am J Physiol 1996;270: G956-G961.
56. Bautista AP. Impact of alcohol on ability of kupffer cells to produce chemokines and ist role in alcoholic liver disease. J Gastroenterol Hepatol 2000;15:349-56.
57. Hoek JB, Khokodenko BN. Intracellular signaling network as a target of ethanol. Alcohol Clin Exp Res 1998;22:S225-S230.
58. Bautista AP. Role of kupffer cells and reactive oxygen species in hepatic injury during acute and chronic alcohol intoxication. Alcohol Clin Exp Res 1998;22:S255-S259.
59. Neoh LP, Akimoto H, Kaneko T. The production of β-chemokines induced by HIV-2 envelope glycoprotein. AIDS 1995;11:1063-4.
60. Klassen LW, Thiele GM. Immune reactivity to proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res 1998;22:S204-S207.
61. Bautista AP, Spitzer JJ. Cross-tolerance between acute alcohol intoxication and endotoxemia. Alcohol Clin Exp Res 1996;20:1395-400.
62. Shenker S, Bay MK. Alcohol and endotoxin: another path to alcoholic liver injury. Alcohol Clin Exp Res 1995;19:1364-6.
63. Enamoto N, Ikejima K, Bradford BU. Alcohol causes both tolerance and sensitization of rat kupffer cells via mechanism dependent on endotoxin. Gastroenterology 1998;115:443-51.
64. Su GL, Rahemtulla A, Thomas P, Klein RD, Wang SC, Nanji AA. CD14 and lipopolysacharide binding protein expression in rat model of alcoholic liver disease. Am J Pathol 1998;152:841-9.
65. Enamoto M, Yamashina S, Kono H. Development of a new, simple rat model of early alcohol induced liver injury based on sensitization of kupffer cells. Hepatology 1999;29:1680-9.
66. Kovacs EJ, Radzioch D, Young HA, Varesio L. Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messanger pathways in murine macrophage. J Immunol 1998; 141:3101-5.
67. Enamoto M, Yamashina M, Goto M, Shemmer P, Thurman RG. Desensitization to LPS after ethanol involves the effect of endotoxin on voltage-dependent calcium channels. Am J Physiol 1999;277:G1251-G1258.
68. Hrubec Z, Omenn GS. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 1981;5:207-15.
69. Chao YC, Liou SR, Chung YY, Tang HS, Hsu CT, Li TK et al. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis an Chinese patients. Hepatology 1994;19:360-6.
70. Chao YC, Young TH, Tang HS, Hsu CT. Alcoholics and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients. Hepatology 1997;25:112-7.
71. Ceni E, Galli A, Casini A. Genetics, alcohol and cirrhosis. Ann In Med 1997;126:1000.
72. Monzoni A, Masutti F, Saccocio G, Bellentani S, Tiribelli C. Genetics determinants of ethanol-induced liver demage. Mol Med 2001;7:255-62.
73. Wong NA, Rae F, Bathgate A, Smith CA, Harrison DJ. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility toalcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol Lett 2000;115:17-22.
74. Grove J, Dayly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 2000;46:540-5.
75. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nature Rev Immunol 2001; 1:220-8.
76. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-50.
77. Stewart S, Jones D, and Day CP. Alcoholic liver disease: new insights into mechanisms and preventive strategies. Trend Mol Med 2001;7:408-13.
78. Jarvelainen HA, Orpana A, Parola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor foralcoholic liver disease. Hepatology 2001;33: 1148-53.